Acasă › Colită ulcerativă › Washington
Studii clinice pentru Colită ulcerativă în Washington
22 studii pentru Colită ulcerativă caută participanți în Washington.
Orașe în Washington
Text oficial al studiului (în engleză)
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Washington Gastroenterology - Bellevue /ID# 283966, Bellevue
- Washington Gastroenterology - Tacoma /ID# 284143, Tacoma
- The Vancouver Clinic /ID# 280497, Vancouver
În curs de recrutareFaza 2
Vârste de la 18 la 75 · Toate sexele · Actualizat 1 oct. 2026 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- GI Alliance, Bellevue
În curs de recrutareFaza 4
Vârste de la 18 la 80 · Toate sexele · Actualizat 30 sept. 2026 · NCT06581328A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
- University of Washington School Medicine, Seattle
În curs de recrutareFaza 2
Vârste de la 18 la 75 · Toate sexele · Actualizat 30 sept. 2026 · NCT06598943A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Site 004, Seattle
- Site 019, Tacoma
În curs de recrutareFaza 2
Vârste de la 18 la 75 · Toate sexele · Actualizat 29 sept. 2026 · NCT07012395A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
- Site US-021, Bellevue
- Site US-029, Tacoma
În curs de recrutareFaza 2
Vârste de la 18 la 75 · Toate sexele · Actualizat 29 sept. 2026 · NCT07845487A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
- GI Alliance Tacoma, Tacoma
În curs de recrutareFaza 3
Vârste de 12 ani și peste · Toate sexele · Actualizat 25 sept. 2026 · NCT07196748A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
- Seattle Children's Hospital, Seattle
- MultiCare Health System, Tacoma
În curs de recrutareFaza 2/3
Vârste de la 2 la 17 · Toate sexele · Actualizat 24 sept. 2026 · NCT05076175Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Washington Gastroenterology - Tacoma, Tacoma
În curs de recrutareFaza 3
Vârste de la 18 la 70 · Toate sexele · Actualizat 24 sept. 2026 · NCT06937086LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- Washington Gastroenterology - Bellevue, Bellevue
În curs de recrutareFaza 2
Vârste de la 18 la 80 · Toate sexele · Actualizat 22 sept. 2026 · NCT07186101LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- Swedish Medical Center, Seattle
- Principle Research Solutions, Spokane
- Providence Sacred Heart Medical Center & Children's Hospital, Spokane
- și încă 1
În curs de recrutareFaza 2
Vârste de la 18 la 80 · Toate sexele · Actualizat 22 sept. 2026 · NCT07415044A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
- Washington Gastroenterology- GIA, Tacoma
În curs de recrutareFaza 4
Vârste de la 18 la 65 · Toate sexele · Actualizat 21 sept. 2026 · NCT06095128A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- The Vancouver Clinic Inc. P.S. - Site Number: 8400090, Vancouver
În curs de recrutareFaza 3
Vârste de la 16 la 80 · Toate sexele · Actualizat 15 sept. 2026 · NCT07185009Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
- Washington Gastroenterology - Tacoma ( Site 0295), Tacoma
În curs de recrutareFaza 3
Toate vârstele · Toate sexele · Actualizat 9 sept. 2026 · NCT06651281A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
- GI Alliance Tacoma, Tacoma
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 28 aug. 2026 · NCT07577856Familial Inflammatory Bowel Disease Early Risk
- Seattle Children's Hospital, Seattle
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
Vârste de la 0 la 55 · Toate sexele · Actualizat 28 aug. 2026 · NCT07791862A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
- University of Washington, Seattle
- Digestive Health Specialists, Tacoma
În curs de recrutareFaza 2
Vârste de la 18 la 80 · Toate sexele · Actualizat 21 aug. 2026 · NCT06636656An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- GI Alliance - Bellevue - Site Number: 8400143, Bellevue
- The Vancouver Clinic Inc. P.S. - Site Number: 8400090, Vancouver
În curs de recrutareFaza 3
Vârste de la 16 la 80 · Toate sexele · Actualizat 20 aug. 2026 · NCT07184996A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
- MultiCare Institute for Research & Innovation, Tacoma
În curs de recrutareFaza 3
Vârste de la 2 la 17 · Toate sexele · Actualizat 3 aug. 2026 · NCT06100289An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
- Washington Gastroenterology, Tacoma
În curs de recrutareStudiu observațional
Vârste de la 18 la 64 · Toate sexele · Actualizat 9 iul. 2026 · NCT06398626A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Multicare Health System Institute for Research and Innovation, Tacoma
În curs de recrutareFaza 3
Vârste de la 2 la 17 · Toate sexele · Actualizat 22 iun. 2026 · NCT06405087Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE)
- Seattle Children's Hospital, Seattle
În curs de recrutareStudiu observațional
Vârste de la 6 la 21 · Toate sexele · Actualizat 24 apr. 2026 · NCT06315179A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Bellevue
- Mirador Therapeutics Selected Site, Silverdale
- Mirador Therapeutics Selected Site, Tacoma
În curs de recrutareFaza 2
Vârste de la 18 la 80 · Toate sexele · Actualizat 12 mar. 2026 · NCT07113522Sursă: ClinicalTrials.gov, date preluate la 2 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.